APA

Pipino C., Mukherjee S., David A. L., Blundell M. P., Shaw S. W., Sung P., Shangaris P., Waters J. J., Ellershaw D., Cavazzana M., Mostoslavsky G., Pandolfi A., Pierro A., Guillot P. V., Thrasher A. J. & De Coppi P. (20150529). Trisomy 21 mid-trimester amniotic fluid induced pluripotent stem cells maintain genetic signatures during reprogramming: implications for disease modeling and cryobanking. : Cellular reprogramming.

Chicago

Pipino Caterina, Mukherjee Sayandip, David Anna L, Blundell Michael P, Shaw Steven W, Sung Peggy, Shangaris Panicos, Waters Jonathan J, Ellershaw Drew, Cavazzana Marina, Mostoslavsky Gustavo, Pandolfi Assunta, Pierro Agostino, Guillot Pascale V, Thrasher Adrian J and De Coppi Paolo. 20150529. Trisomy 21 mid-trimester amniotic fluid induced pluripotent stem cells maintain genetic signatures during reprogramming: implications for disease modeling and cryobanking. : Cellular reprogramming.

Harvard

Pipino C., Mukherjee S., David A. L., Blundell M. P., Shaw S. W., Sung P., Shangaris P., Waters J. J., Ellershaw D., Cavazzana M., Mostoslavsky G., Pandolfi A., Pierro A., Guillot P. V., Thrasher A. J. and De Coppi P. (20150529). Trisomy 21 mid-trimester amniotic fluid induced pluripotent stem cells maintain genetic signatures during reprogramming: implications for disease modeling and cryobanking. : Cellular reprogramming.

MLA

Pipino Caterina, Mukherjee Sayandip, David Anna L, Blundell Michael P, Shaw Steven W, Sung Peggy, Shangaris Panicos, Waters Jonathan J, Ellershaw Drew, Cavazzana Marina, Mostoslavsky Gustavo, Pandolfi Assunta, Pierro Agostino, Guillot Pascale V, Thrasher Adrian J and De Coppi Paolo. Trisomy 21 mid-trimester amniotic fluid induced pluripotent stem cells maintain genetic signatures during reprogramming: implications for disease modeling and cryobanking. : Cellular reprogramming. 20150529.